Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).

Kristina Secnik Boye Jiat Ling Poon Laura Fernández Landó Hélène Sapin Ruth Huh Mianbo Wang Suzanne Williamson Hiren Patel

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

In adult patients with T2D and inadequate glycaemic control with basal insulin, tirzepatide treatment was associated with greater improvements in HRQoL than prandial insulin therapy in addition to clinically significant improvements in glycaemic and body weight-related parameters.

Keyphrases

type diabetes
body weight
glycemic control
study protocol
insulin resistance
randomized controlled trial
metabolic syndrome
phase iii
weight loss